Cell Biology/Signaling |
From the Atherothrombosis Research Laboratory, Division of Cardiovascular Sciences (J.O., J.A.R., C.R., S.M.d.L., J.B., J.A.P.), Center for Applied Medical Research (CIMA)-University of Navarra, Pamplona, Spain; Centro de Investigación Cardiovascular (CSIC-ICCC) (O.C., R.R.-C., C.R., J.M.-G.), Hospital de la Santa Creu I Sant Pau, Barcelona, Spain; the Department of Haemotherapy and Haemostasis (J.C.R.), Hospital Clinic, University of Barcelona, Spain; and the Hematology Service (J.A.P.), University Clinic, University of Navarra, Pamplona, Spain.
Correspondence to José A. Páramo, Atherothrombosis Research Laboratory, Division of Cardiovascular Science, CIMA-University of Navarra, Avda. Pio XII, 55 31008 Pamplona, Navarra, Spain. E-mail japaramo{at}unav.es José Martínez-González, Centro de Investigación Cardiovascular (CSIC-ICCC), Hospital de la Santa Creu I Sant Pau, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain. E-mail jmartinez@csic-iccc.org.
Objective— Thrombin is a multifunctional serine protease that promotes vascular proinflammatory responses whose effect on endothelial MMP-10 expression has not previously been evaluated.
Methods and Results— Thrombin induced endothelial MMP-10 mRNA and protein levels, through a protease-activated receptor-1 (PAR-1)–dependent mechanism, in a dose- and time-dependent manner. This effect was mimicked by a PAR-1 agonist peptide (TRAP-1) and antagonized by an anti–PAR-1 blocking antibody. MMP-10 induction was dependent on extracellular regulated kinase1/2 (ERK1/2) and c-jun N-terminal kinase (JNK) pathways. By serial deletion analysis, site-directed mutagenesis and electrophoretic mobility shift assay an AP-1 site in the proximal region of MMP-10 promoter was found to be critical for thrombin-induced MMP-10 transcriptional activity. Thrombin and TRAP-1 upregulated MMP-10 in murine endothelial cells in culture and in vivo in mouse aorta. This effect of thrombin was not observed in PAR-1–deficient mice. Interestingly, circulating MMP-10 levels (P<0.01) were augmented in patients with endothelial activation associated with high (disseminated intravascular coagulation) and moderate (previous acute myocardial infarction) systemic thrombin generation.
Conclusion— Thrombin induces MMP-10 through a PAR-1–dependent mechanism mediated by ERK1/2, JNK, and AP-1 activation. Endothelial MMP-10 upregulation could be regarded as a new proinflammatory effect of thrombin whose pathological consequences in thrombin-related disorders and plaque stability deserve further investigation.
Thrombin can interact with extracellular matrix components and promote vascular proinflammatory responses including MMP upregulation. We show that thrombin induces endothelial MMP-10, in vitro and in vivo, through a PAR-1–dependent mechanism mediated by ERK1/2, JNK, and AP-1 activation. Increased MMP-10 can be observed in pathologies with augmented thrombin generation.
Key Words: thrombin endothelium MMP-10 atherosclerosis thrombosis
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |